Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01471457Phase 3Completed
Phase 3, randomised, open-label trial of hydroxyquinolone in bacterial vaginosis (BV) (2 arms), sponsored by The University of New Mexico. Primary endpoint: Number of Patients With Bacterial Vaginosis at 3 Months. Started Sep 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01471457.